
    <!DOCTYPE html>
    <html>
    <head>
        <style>
            body { 
                font-family: 'Segoe UI', Roboto, -apple-system, sans-serif; 
                max-width: 1200px; 
                margin: 0 auto; 
                padding: 20px; 
                background-color: #f0f2f5;
                line-height: 1.6;
            }
            .container { 
                background-color: white; 
                padding: 40px; 
                border-radius: 16px; 
                box-shadow: 0 4px 12px rgba(0,0,0,0.1);
            }
            .agent-section { 
                margin-bottom: 35px; 
                padding: 25px; 
                border-radius: 12px; 
                transition: all 0.3s ease;
            }
            .agent-section:hover {
                transform: translateY(-2px);
                box-shadow: 0 4px 15px rgba(0,0,0,0.1);
            }
            .final-annotation { 
                background-color: #f0f7ff; 
                border-left: 5px solid #2196f3; 
            }
            .validator { 
                background-color: #f0fdf4; 
                border-left: 5px solid #22c55e; 
            }
            .formatting { 
                background: linear-gradient(145deg, #fff7ed, #ffe4c4);
                border-left: 5px solid #f97316; 
                box-shadow: 0 4px 15px rgba(249, 115, 22, 0.1);
            }
            h2 { 
                color: #1a2b3c; 
                margin-top: 0; 
                font-size: 1.5rem;
                font-weight: 600;
                display: flex;
                align-items: center;
                gap: 10px;
            }
            ul { 
                margin: 15px 0; 
                padding-left: 20px; 
            }
            pre { 
                background-color: #f8fafc; 
                padding: 20px; 
                border-radius: 8px; 
                overflow-x: auto;
                font-family: 'Consolas', 'Monaco', monospace;
                font-size: 0.9rem;
                line-height: 1.5;
            }
            .validation-result { 
                font-weight: 600; 
                color: #16a34a; 
                padding: 12px 20px;
                background-color: #dcfce7; 
                border-radius: 8px; 
                display: inline-block;
                margin: 10px 0;
            }
            br { 
                margin-bottom: 8px; 
            }
            p {
                margin: 12px 0;
                color: #374151;
            }
            .summary-content {
                display: flex;
                flex-direction: column;
                gap: 24px;
            }
            .summary-item {
                display: flex;
                flex-direction: column;
                gap: 8px;
                background: rgba(255, 255, 255, 0.7);
                padding: 16px;
                border-radius: 12px;
                backdrop-filter: blur(8px);
                box-shadow: 0 2px 8px rgba(0, 0, 0, 0.05);
            }
            .summary-label {
                font-weight: 600;
                color: #c2410c;
                font-size: 0.95rem;
                text-transform: uppercase;
                letter-spacing: 0.5px;
            }
            .summary-value {
                color: #1f2937;
                font-size: 1.1rem;
                padding: 8px 16px;
                background-color: rgba(255, 255, 255, 0.9);
                border-radius: 8px;
                display: inline-block;
                box-shadow: 0 1px 3px rgba(0, 0, 0, 0.1);
            }
            .summary-list {
                margin: 0;
                padding-left: 24px;
                list-style-type: none;
            }
            .summary-list li {
                color: #1f2937;
                padding: 8px 0;
                position: relative;
            }
            .summary-list li:before {
                content: "‚Ä¢";
                color: #f97316;
                font-weight: bold;
                position: absolute;
                left: -20px;
            }
            .report-header {
                text-align: center;
                margin-bottom: 40px;
                padding-bottom: 30px;
                border-bottom: 2px solid rgba(249, 115, 22, 0.2);
            }
            
            .report-title {
                font-size: 2.5rem;
                font-weight: 800;
                color: #1a2b3c;
                margin: 0;
                padding: 0;
                background: linear-gradient(135deg, #f97316, #c2410c);
                -webkit-background-clip: text;
                -webkit-text-fill-color: transparent;
                letter-spacing: -0.5px;
            }
            
            .report-subtitle {
                font-size: 1.1rem;
                color: #64748b;
                margin-top: 8px;
                font-weight: 500;
            }
            .scoring { 
                background: linear-gradient(145deg, #f0fdf4, #dcfce7);
                border-left: 5px solid #22c55e;
                box-shadow: 0 4px 15px rgba(34, 197, 94, 0.1);
            }
            .scoring-content {
                display: flex;
                flex-direction: column;
                gap: 16px;
                color: #1f2937;
                line-height: 1.8;
            }
            .scoring-content br + br {
                content: "";
                display: block;
                margin: 12px 0;
            }
            .empty-list {
                color: #6b7280;
                font-style: italic;
            }
            .error-message {
                color: #dc2626;
                padding: 12px;
                background-color: #fef2f2;
                border-radius: 6px;
                border-left: 4px solid #dc2626;
            }
            .score-badge {
                background: linear-gradient(135deg, #22c55e, #16a34a);
                color: white;
                padding: 8px 16px;
                border-radius: 12px;
                font-size: 1.5rem;
                font-weight: 700;
                display: inline-block;
                margin: 12px 0;
                box-shadow: 0 4px 12px rgba(34, 197, 94, 0.2);
                position: relative;
                top: -10px;
            }
            .score-badge::before {
                content: "Score:";
                font-size: 0.9rem;
                font-weight: 500;
                margin-right: 8px;
                opacity: 0.9;
            }
        </style>
    </head>
    <body>
        <div class="container">
            <div class="report-header">
                <h1 class="report-title">CASSIA Analysis Report</h1>
                <p class="report-subtitle">Comprehensive Cell Type Analysis and Annotation</p>
            </div>
            
                <div class="agent-section final-annotation">
                    <h2>üîç Final Annotation Analysis</h2>
                    To annotate the cell type based on the provided ranked marker list from a single-cell human dataset derived from breast cancer tissue, I will follow the outlined steps:<br><br>### Step 1: List the Key Functional Markers<br>- **ATP Synthase Complex Components (ATP5E, ATP5L, ATP5G2, ATP5G3, ATP5J2, ATP5D, ATP5J, ATP5O, ATP5H, ATP5B, ATP5I, ATP5C1, ATP5F1, ATP5A1):** These genes encode subunits of the ATP synthase complex, which is crucial for ATP production in mitochondria, indicating high metabolic activity.<br>- **GPX1 (Glutathione Peroxidase 1):** Involved in the detoxification of hydrogen peroxide, suggesting a role in oxidative stress response.<br>- **SQRDL (Sulfide Quinone Reductase-Like):** Involved in mitochondrial sulfide oxidation, indicating mitochondrial function.<br>- **GNB2L1 (Guanine Nucleotide Binding Protein Beta Polypeptide 2-Like 1):** Involved in signal transduction.<br>- **TCEB1, TCEB2 (Transcription Elongation Factor B):** Part of the transcription elongation complex, indicating active transcriptional regulation.<br>- **SELT (Selenoprotein T), SELK (Selenoprotein K), SEP15 (Selenoprotein 15):** Involved in redox homeostasis and protein folding.<br>- **SPP1 (Secreted Phosphoprotein 1):** Also known as osteopontin, involved in cell adhesion and migration.<br><br>### Step 2: List the Key Cell Type Markers<br>- **C1QA, C1QB, C1QC:** Components of the complement system, typically associated with immune cells, particularly macrophages.<br>- **TYROBP (TYRO Protein Tyrosine Kinase Binding Protein):** Associated with immune cell signaling, particularly in myeloid cells.<br>- **APOE (Apolipoprotein E):** Involved in lipid metabolism, often expressed in macrophages.<br>- **CD14, FCER1G (Fc Fragment of IgE Receptor Ig):** Markers of myeloid lineage, particularly monocytes and macrophages.<br>- **AIF1 (Allograft Inflammatory Factor 1):** Also known as IBA1, a marker for microglia and macrophages.<br>- **CD68:** A well-known marker for macrophages.<br>- **APOC1 (Apolipoprotein C1):** Involved in lipid metabolism, often expressed in macrophages.<br><br>### Step 3: Cross-reference Known Databases<br>Using databases such as the Human Cell Atlas, PanglaoDB, and literature on breast cancer tissue, the markers C1QA, C1QB, C1QC, TYROBP, CD14, CD68, and AIF1 are strongly associated with macrophages. The presence of ATP synthase components suggests high metabolic activity, which is consistent with the energy demands of immune cells in a tumor microenvironment.<br><br>### Step 4: Determine the Most Probable General Cell Type<br>Based on the expression of complement components, immune signaling molecules, and macrophage-specific markers, the most probable general cell type is **macrophages**.<br><br>### Step 5: Identify the Top 3 Most Probable Sub Cell Types<br>1. **Tumor-Associated Macrophages (TAMs):** Given the context of breast cancer tissue, TAMs are a likely subtype due to their role in tumor progression and immune modulation.<br>2. **M1 Macrophages:** Characterized by pro-inflammatory activity, which may be indicated by the presence of oxidative stress markers like GPX1.<br>3. **M2 Macrophages:** Associated with tissue repair and anti-inflammatory responses, potentially indicated by the presence of lipid metabolism markers like APOE and APOC1.<br><br>The most likely subtype, considering the tumor context and the presence of markers like SPP1 and APOE, is **Tumor-Associated Macrophages (TAMs)**.<br><br>### Step 6: Provide a Concise Summary of Your Analysis<br>The analysis of the ranked marker list from the breast cancer tissue dataset suggests that the cell cluster is most likely composed of macrophages, specifically tumor-associated macrophages (TAMs). This conclusion is supported by the presence of complement components, macrophage-specific markers, and genes involved in lipid metabolism and oxidative stress response, which are characteristic of TAMs in the tumor microenvironment.<br><br>**FINAL ANNOTATION COMPLETED**
                </div>
            
                <div class="agent-section validator">
                    <h2>‚úì Validation Check</h2>
                    <div class="validation-result">‚úÖ VALIDATION PASSED</div>
                    Validation result: VALIDATION PASSED<br><br>The proposed annotation result is consistent with the provided marker list and the context of breast cancer tissue. Here's the breakdown of the validation:<br><br>1. **Marker Consistency:**<br>   - The key functional markers and cell type markers listed in the annotation are present in the provided marker list. <br>   - The markers associated with ATP synthase components, oxidative stress response, and lipid metabolism are consistent with high metabolic activity and immune cell function, which are relevant in the context of tumor-associated macrophages (TAMs).<br><br>2. **Mixed Cell Type Consideration:**<br>   - The annotation primarily identifies macrophages, specifically tumor-associated macrophages (TAMs), as the cell type. The presence of markers like C1QA, C1QB, C1QC, TYROBP, CD14, CD68, and AIF1 strongly supports this identification.<br>   - There is no strong evidence of multiple distinct cell types based on the high-ranking markers provided. The markers are predominantly associated with macrophages, particularly in the tumor microenvironment.<br><br>The annotation accurately reflects the likely cell type and subtype based on the marker list and the context of breast cancer tissue. Therefore, the validation is passed.
                </div>
            
                        <div class="agent-section formatting">
                            <h2>üìã Summary</h2>
                            
                        <div class="summary-content">
                            <div class="summary-item">
                                <span class="summary-label">Main Cell Type:</span>
                                <span class="summary-value">macrophages</span>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Sub Cell Types:</span>
                                <ul class="summary-list">
                                    <li>Tumor-Associated Macrophages (TAMs)</li><li>M1 Macrophages</li><li>M2 Macrophages</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Possible Mixed Cell Types:</span>
                                <ul class="summary-list">
                                    <li class="empty-list">No mixed cell types identified</li>
                                </ul>
                            </div>
                            
                            <div class="summary-item">
                                <span class="summary-label">Number of Markers:</span>
                                <span class="summary-value">50</span>
                            </div>
                        </div>
                    
                        </div>
                    
                    <div class="agent-section scoring">
                        <h2>üéØ Quality Assessment</h2>
                        <div class="score-badge">85</div>
                        <div class="scoring-content">
                            The annotation results provided for the single-cell dataset from human breast cancer tissue are generally well-reasoned and scientifically accurate. The analysis correctly identifies macrophages, specifically tumor-associated macrophages (TAMs), as the primary cell type, which is consistent with the context of breast cancer tissue. The use of markers such as C1QA, C1QB, C1QC, TYROBP, CD14, CD68, and AIF1 strongly supports this identification, as these are well-known markers for macrophages.<br><br>The annotation also considers the presence of ATP synthase components, which indicate high metabolic activity, a characteristic of immune cells in a tumor microenvironment. This is a strength of the analysis, as it demonstrates a balanced consideration of both functional and cell type-specific markers.<br><br>However, there are a few areas where the analysis could be improved. While the annotation does a good job of identifying macrophages, it could have explored the possibility of other cell types or subtypes that might be present, given the diverse nature of tumor microenvironments. For instance, the presence of markers like SPP1 (osteopontin) could suggest other cell types involved in cell adhesion and migration, such as certain stromal cells or fibroblasts, which are also common in tumor environments.<br><br>Additionally, while the annotation history mentions the rank of markers, it does not explicitly discuss how the rank influenced the final annotation. A more detailed consideration of the rank and its impact on the annotation could have strengthened the analysis.<br><br>Overall, the annotation provides a comprehensive view of the cell types present, with a strong focus on macrophages, particularly TAMs. It effectively uses a range of markers to support its conclusions, but there is room for a more nuanced exploration of potential mixed cell types and the influence of marker rank.<br>
                        </div>
                    </div>
                
        </div>
    </body>
    </html>
    